NCT06131346View on ClinicalTrials.gov

Clinical Characterization and Outcome of Anti-IgLON5 Disease

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

May 31, 2023

Study Completion Date

December 31, 2023

Conditions
Anti-IgLON5 Disease
Interventions
OTHER

Evaluation of clinical and paraclinical data.

Retrospective data collection from available medical files of patient.

Trial Locations (1)

69677

RECRUITING

Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER